Published in JAMA on November 03, 1999
Mechanisms for insulin resistance: common threads and missing links. Cell (2012) 6.85
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology (2010) 5.35
Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology (2010) 3.73
Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol (2008) 3.33
Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab (2011) 2.75
Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol (2008) 2.45
Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med (2008) 2.14
The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol (2011) 2.02
Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice. Proc Natl Acad Sci U S A (2012) 1.72
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology (2008) 1.70
NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver (2012) 1.70
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. Cell Metab (2012) 1.64
Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol (2007) 1.59
Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology (2012) 1.57
High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology (2013) 1.56
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol (2013) 1.56
Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver. J Lipid Res (2012) 1.53
Steatosis as a risk factor in liver surgery. Ann Surg (2007) 1.48
Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol (2003) 1.47
Metabolic syndrome and the hepatorenal reflex. Surg Neurol Int (2016) 1.40
Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol (2010) 1.40
Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr (2011) 1.29
Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS One (2012) 1.24
Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion. J Biol Chem (2007) 1.19
Health implications of fructose consumption: A review of recent data. Nutr Metab (Lond) (2010) 1.15
Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet. PLoS One (2011) 1.04
Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol (2003) 1.02
Pathogenesis of Nonalcoholic Steatohepatitis. Gastroenterology (2016) 1.02
Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci (2014) 1.00
Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J Gastroenterol (2014) 0.99
Mitochondrial morphology in metabolic diseases. Antioxid Redox Signal (2012) 0.98
Mitochondria and redox signaling in steatohepatitis. Antioxid Redox Signal (2011) 0.96
Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol (2008) 0.96
Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion. Am J Physiol Gastrointest Liver Physiol (2009) 0.95
Non-alcoholic fatty liver disease: an emerging pathological spectrum. Virchows Arch (2003) 0.93
Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective. Oxid Med Cell Longev (2014) 0.92
Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci (2014) 0.92
Hepatic Steatosis as a Marker of Metabolic Dysfunction. Nutrients (2015) 0.92
Perspectives on: SGP symposium on mitochondrial physiology and medicine: what comes first, misshape or dysfunction? The view from metabolic excess. J Gen Physiol (2012) 0.90
Translational approaches: from fatty liver to non-alcoholic steatohepatitis. World J Gastroenterol (2014) 0.87
New aspects of mitochondrial Uncoupling Proteins (UCPs) and their roles in tumorigenesis. Int J Mol Sci (2011) 0.87
Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy. Liver Int (2008) 0.87
Multiple classes of environmental chemicals are associated with liver disease: NHANES 2003-2004. Int J Hyg Environ Health (2013) 0.87
Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity. PPAR Res (2012) 0.86
Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver. Antioxid Redox Signal (2014) 0.84
Attention-deficit/hyperactivity disorder: is it time to reappraise the role of sugar consumption? Postgrad Med (2011) 0.84
The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans. Curr Cardiovasc Risk Rep (2012) 0.84
An Intimate Relationship between ROS and Insulin Signalling: Implications for Antioxidant Treatment of Fatty Liver Disease. Int J Cell Biol (2014) 0.84
Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion. Transplant Proc (2009) 0.83
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. Dig Dis Sci (2016) 0.83
Insulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain. Diabetes (2016) 0.82
Insulin induces a positive relationship between the rates of ATP and glycogen changes in isolated rat liver in presence of glucose; a 31P and 13C NMR study. Nutr Metab (Lond) (2005) 0.81
OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease. PLoS One (2015) 0.81
Fructose protects murine hepatocytes from tumor necrosis factor-induced apoptosis by modulating JNK signaling. J Biol Chem (2011) 0.81
Dietary sugars: a fat difference. J Clin Invest (2009) 0.81
Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis. J Clin Exp Hepatol (2012) 0.81
Oral fructose absorption in obese children with non-alcoholic fatty liver disease. Pediatr Obes (2014) 0.80
Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease. Eur Radiol (2004) 0.80
Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model. Braz J Med Biol Res (2015) 0.80
L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway. PLoS One (2014) 0.79
Transition between acute and chronic hepatotoxicity in mice is associated with impaired energy metabolism and induction of mitochondrial heme oxygenase-1. PLoS One (2013) 0.79
Flare-up of nonalcoholic steatohepatitis after hepatectomy resulted in hepatic failure in a patient with type 2 diabetes mellitus. Dig Dis Sci (2007) 0.78
Liver AMP-Activated Protein Kinase Is Unnecessary for Gluconeogenesis but Protects Energy State during Nutrient Deprivation. PLoS One (2017) 0.78
NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol (2016) 0.77
Fructokinase, Fructans, Intestinal Permeability, and Metabolic Syndrome: An Equine Connection? J Equine Vet Sci (2013) 0.77
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma. Sci Rep (2015) 0.75
Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphate. PLoS One (2012) 0.75
Metabolic syndrome and the hepatorenal reflex. Surg Neurol Int (2016) 0.75
Monitoring acute metabolic changes in the liver and kidneys induced by fructose and glucose using hyperpolarized [2-(13) C]dihydroxyacetone. Magn Reson Med (2016) 0.75
Increased Hepatic Fatty Acids Uptake and Oxidation by LRPPRC-Driven Oxidative Phosphorylation Reduces Blood Lipid Levels. Front Physiol (2016) 0.75
Effects of exercise training on intrahepatic lipid content in humans. Diabetologia (2016) 0.75
A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD. PLoS Comput Biol (2016) 0.75
Potential of (99m)Tc-MIBI SPECT imaging for evaluating non-alcoholic steatohepatitis induced by methionine-choline-deficient diet in mice. EJNMMI Res (2014) 0.75
In-vivo (31)P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism. Anal Biochem (2017) 0.75
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res (2017) 0.75
The ABCC6 Transporter: A New Player in Biomineralization. Int J Mol Sci (2017) 0.75
Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis. JCI Insight (2017) 0.75
The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease. Children (Basel) (2017) 0.75
Measuring short-term liver metabolism non-invasively: postprandial and post-exercise ¹H and ³¹P MR spectroscopy. MAGMA (2014) 0.75
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol (1999) 17.45
Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med (2000) 5.13
Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science (1994) 4.81
Leptin regulates proinflammatory immune responses. FASEB J (1998) 4.31
Do patients cash prescriptions? Br Med J (Clin Res Ed) (1982) 4.11
Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med (1989) 4.07
Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A (1997) 3.79
Skill-mix in primary care: sharing clinical workload and understanding professional roles. Br J Gen Pract (1996) 3.49
Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med (2000) 3.47
A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci U S A (1993) 3.33
Inheritance and effect on ripening of antisense polygalacturonase genes in transgenic tomatoes. Plant Mol Biol (1990) 2.95
Histopathological identification of colon cancer with microsatellite instability. Am J Pathol (2001) 2.90
Animal models of steatosis. Semin Liver Dis (2001) 2.88
Knowledge and attitude on screening mammography among low-literate, low-income women. Cancer (1996) 2.81
General practice in deprived areas: problems and solutions. Br J Gen Pract (1993) 2.56
Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol (1992) 2.33
Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann Intern Med (1989) 2.28
The hedgehog pathway regulates remodelling responses to biliary obstruction in rats. Gut (2008) 2.26
Does the MRCGP examination discriminate against Asian doctors? BMJ (1992) 2.17
Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology (2001) 2.14
Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology (2000) 2.10
Multiple origins of cultivated grapevine (Vitis vinifera L. ssp. sativa) based on chloroplast DNA polymorphisms. Mol Ecol (2006) 2.02
Norwalk-like viruses: demonstration of genomic diversity by polymerase chain reaction. J Clin Microbiol (1993) 1.96
Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem (1999) 1.94
Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer (2007) 1.87
The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology (1995) 1.86
Intracellular free calcium concentration measured with 19F NMR spectroscopy in intact ferret hearts. Proc Natl Acad Sci U S A (1987) 1.80
What determines competence within a general practice consultation? Assessment of consultation skills using simulated surgeries. Br J Gen Pract (1998) 1.80
Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119) Hepatology (1991) 1.78
MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene (2008) 1.78
Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut (2003) 1.77
Zygotic lethal mutations with maternal effect phenotypes in Drosophila melanogaster. II. Loci on the second and third chromosomes identified by P-element-induced mutations. Genetics (1996) 1.76
Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys (2000) 1.74
A polio immunization pamphlet with increased appeal and simplified language does not improve comprehension to an acceptable level. Patient Educ Couns (1998) 1.73
Characteristics of general practices associated with emergency admission rates to hospital: a cross-sectional study. Emerg Med J (2011) 1.65
Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology (2000) 1.63
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther (2004) 1.61
Improving patient education for patients with low literacy skills. Am Fam Physician (1996) 1.60
Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task. Mol Psychiatry (2010) 1.57
Relation between literacy and HIV treatment knowledge among patients on HAART regimens. AIDS Care (2005) 1.56
Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. Am J Pathol (1998) 1.55
Control and manipulation of gene expression during tomato fruit ripening. Plant Mol Biol (1989) 1.53
Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Virology (1989) 1.53
Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res (2001) 1.52
Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol (1999) 1.51
Bright solid-state sources of indistinguishable single photons. Nat Commun (2013) 1.51
Septic arthritis caused by Propionibacterium acnes. JAMA (1982) 1.45
Hepatitis B antigen (HBAg) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAg. Can Med Assoc J (1975) 1.45
Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci U S A (1998) 1.44
Parent comprehension of polio vaccine information pamphlets. Pediatrics (1996) 1.44
Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene (2007) 1.44
Senescence and the renal vasculature in normal man. Circ Res (1974) 1.43
Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res (2001) 1.42
Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut (2004) 1.42
Comparative 13C and 31P NMR assessment of altered metabolism during graded reductions in coronary flow in intact rat hearts. Proc Natl Acad Sci U S A (1989) 1.41
Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy. Liver (2000) 1.39
Facial herpes simplex infection from possible cross contamination through the laser hand-piece following cutaneous laser resurfacing. J Plast Reconstr Aesthet Surg (2006) 1.39
Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol (1998) 1.39
Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings. Am J Surg Pathol (2001) 1.39
Genome-sequence-based fluorescent amplified-fragment length polymorphism analysis of Mycobacterium tuberculosis. J Clin Microbiol (2000) 1.36
Potentially avoidable emergency department attendance: interview study of patients' reasons for attendance. Emerg Med J (2011) 1.35
Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating mice [correction of rat] liver. Hepatology (1999) 1.34
Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology (1999) 1.33
Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. Am J Physiol (1999) 1.32
An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J Virol (1991) 1.31
Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. J Hepatol (2003) 1.31
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation. Cancer (2001) 1.28
Quantification of [Ca2+]i in perfused hearts. Critical evaluation of the 5F-BAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circ Res (1990) 1.27
Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. Gastroenterology (1999) 1.27
Bone densitometry in Canadian children 8-17 years of Age. Calcif Tissue Int (1996) 1.26
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest (2011) 1.26
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut (2006) 1.26
Prognostic value of response after upfront therapy for acute GVHD. Bone Marrow Transplant (2011) 1.26
Characteristics of general practices associated with emergency-department attendance rates: a cross-sectional study. BMJ Qual Saf (2011) 1.25
Fluorescent amplified-fragment length polymorphism genotyping of Neisseria meningitidis identifies clones associated with invasive disease. J Clin Microbiol (2000) 1.25
Kupffer cell depletion by gadolinium chloride enhances liver regeneration after partial hepatectomy in rats. Am J Physiol (1996) 1.25
Tumor necrosis factor alpha promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes. J Biol Chem (1996) 1.22
Factors that mediate and moderate the link between partner abuse and suicidal behavior in African American women. J Consult Clin Psychol (1998) 1.22
Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J Biol Chem (1998) 1.22
Vitamin D state of Asians living in Pakistan. Br Med J (Clin Res Ed) (1983) 1.21
Analysis of promoters in Borrelia burgdorferi by use of a transiently expressed reporter gene. J Bacteriol (1997) 1.21
Comparison of gastrointestinal tolerance to two enteral feeding protocols in critically ill patients: a prospective, randomized controlled trial. JPEN J Parenter Enteral Nutr (2001) 1.21
Cytokines and alcoholic liver disease. Semin Liver Dis (1993) 1.20
Altered high-energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice. Am J Physiol Heart Circ Physiol (2006) 1.18
Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging. Int J Obes (Lond) (2007) 1.18
Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology (1995) 1.18
Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene (2001) 1.17
Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol Gastrointest Liver Physiol (2001) 1.16
Lethal tricuspid and mitral regurgitation in Marfan's syndrome. Am J Cardiol (1967) 1.16
Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps. Am J Pathol (1997) 1.15
Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res (1998) 1.15
Liver disease in kidney transplant patients receiving azathioprine. Arch Intern Med (1973) 1.15
Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology (1997) 1.14
'Brown bag' medication reviews as a means of optimizing patients' use of medication and of identifying potential clinical problems. Fam Pract (1999) 1.13
Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol (2001) 1.12